Effect of tocopherol supplementation during last trimester of pregnancy on mRNA abundances of interleukins and angiogenesis in ovine placenta and uterus

<p>Abstract</p> <p>Background</p> <p>Interleukins (IL) play an important role in angiogenesis. Tocopherol possesses immunomodulating effect in addition to antioxidant property. The objective of this study was to determine whether gamma tocopherol's (gT) angiogenic...

Full description

Saved in:
Bibliographic Details
Main Authors: Kasimanickam Ramanathan K (Author), Kasimanickam Vanmathy R (Author), Haldorson Gary J (Author), Tibary Ahmed (Author)
Format: Book
Published: BMC, 2012-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_c6e9310d06a44dc3a5ec17c98f9efd47
042 |a dc 
100 1 0 |a Kasimanickam Ramanathan K  |e author 
700 1 0 |a Kasimanickam Vanmathy R  |e author 
700 1 0 |a Haldorson Gary J  |e author 
700 1 0 |a Tibary Ahmed  |e author 
245 0 0 |a Effect of tocopherol supplementation during last trimester of pregnancy on mRNA abundances of interleukins and angiogenesis in ovine placenta and uterus 
260 |b BMC,   |c 2012-01-01T00:00:00Z. 
500 |a 10.1186/1477-7827-10-4 
500 |a 1477-7827 
520 |a <p>Abstract</p> <p>Background</p> <p>Interleukins (IL) play an important role in angiogenesis. Tocopherol possesses immunomodulating effect in addition to antioxidant property. The objective of this study was to determine whether gamma tocopherol's (gT) angiogenic activity in placental network is enhanced via promoting interleukins.</p> <p>Methods</p> <p>Pregnant ewes (N = 18) were supplemented, orally, with 500 mg of alpha tocopherol (aT; N = 6) or 1,000 mg of gT (N = 7) or placebo (CON; N = 5) once daily from 107 to 137 days post breeding. Uterine and placental tissue samples were obtained at the end of supplementation to evaluate relative mRNA expressions of IL-1b, IL-6, IL-8, Tumor Necrosis Factor (TNF) alpha, Vascular Endothelial Growth Factor (VEGF), kinase insert domain receptor (KDR; VGFR2; a type III receptor tyrosine kinase), and soluble fms-like tyrosine kniase-1 (sFlt1 or sVEGFR1) in uterus, caruncle and cotyledon.</p> <p>Results</p> <p>Oral supplementation of gT increased IL-6, IL-8, KDR and VEGF mRNA abundances whereas sFlt1 mRNA abundance was suppressed in uterus, caruncle and cotyledon, compared to aT and placebo treated ewes (<it>P </it>< 0.05). The TNF alpha and IL-1b mRNA abundances were suppressed in uterus, caruncle and cotyledon but TNF alpha is higher in gT group compared to aT group (<it>P </it>< 0.05), whereas IL-1b was similar between treatment groups (<it>P </it>> 0.1).</p> <p>Conclusions</p> <p>Gamma tocopherol supplementation increased IL-6, IL-8, and KDR mRNA abundances and suppressed sFlt1 and TNFalpha mRNA abundances thereby increased VEGF mRNA expression and angiogenesis in placental vascular network during late gestation. It is plausible that the angiogenic effect of gamma tocopherol in placental vascular network is exerted via an alternate path by enhancing IL-6 and IL-8.</p> 
546 |a EN 
690 |a Gynecology and obstetrics 
690 |a RG1-991 
690 |a Reproduction 
690 |a QH471-489 
655 7 |a article  |2 local 
786 0 |n Reproductive Biology and Endocrinology, Vol 10, Iss 1, p 4 (2012) 
787 0 |n http://www.rbej.com/content/10/1/4 
787 0 |n https://doaj.org/toc/1477-7827 
856 4 1 |u https://doaj.org/article/c6e9310d06a44dc3a5ec17c98f9efd47  |z Connect to this object online.